Website logo DLD News

Thomas Clozel

Headshot portrait of medical AI expert Thomas Clozel, CEO and Co-founder of Owkin, smiling at the camera, wearing casual clothes.

Owkin

French entrepreneur and oncologist Thomas Clozel is CEO and Co-founder of Owkin, a pioneering AI company that leverages machine learning to enhance medical research. His work focuses on bridging the gap between advanced technology and healthcare to revolutionize the way we understand and treat diseases.

Full ProfileVideosEvents

Videos

Thomas Clozel, (OWKIN), Christina Nesheva, (Officinae Bio), Edward Shenderovich, (Synonym) and Azeem Azhar, (Exponential View) on stage at the DLD Munich Conference 2025, with audience members visible in the foreground.

Biology’s ChatGPT Moment

AI-driven innovation in biotech, medicine and material science promises a transition from a fossil-based economy to a more sustainable. Moderated by Azeem Azhar (Exponential View), this DLD25 expert panel discussion brings together Christina Nesheva…
Video details

Events

DLD25 graphic design

DLD Munich 2025

Europe’s leading innovation conference celebrates its 20th anniversary from January 16-18, 2025, in Munich. Find out about speakers, location details and how to attend…
Event details
All SpeakersVideo Archive
magnifiercrosschevron-downmenu-circle
linkedin facebook pinterest youtube rss twitter instagram facebook-blank rss-blank linkedin-blank pinterest youtube twitter instagram